Michael Groessl

Michael Groessl

Auto-generated profile, based on publicly available information

Michael Groessl

Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2008 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PDF file
CHChristian Hartinger
Christian Hartinger
MJMichael A. Jakupec
Michael A. Jakupec
SZStefanie Zorbas‐Seifried
Stefanie Zorbas‐Seifried
MGMichael Groessl
Michael Groessl
AEAlexander Egger
Alexander Egger
BKBernhard K. Keppler
Bernhard K. Keppler

1 February 2019 in Mass Spectrometry Reviews
Verified
Journal Article
Open access
PDF file
VGValérie Gabelica
Valérie Gabelica
ASAlexandre A. Shvartsburg
Alexandre A. Shvartsburg
Carlos AfonsoCarlos Afonso
Carlos Afonso
PBPerdita Barran
Perdita Barran
JBJustin L.P. Benesch
Justin L.P. Benesch
TWThomas Wyttenbach
Thomas Wyttenbach
Here we present a guide to ion mobility mass spectrometry experiments, which covers both linear and nonlinear methods: what is measured, how the measurements are done, and how to report the results, including the uncertainties of mobility and collision cross section values. The guide aims to clarify some possibly confusing concepts, and the reporting recommendations should help researchers, authors and reviewers to contribute comprehensive reports, so that the ion mobility data can be reused more confidently. Starting from the concept of the definition of the measurand, we emphasize that (i) mobility values (K0) depend intrinsically on ion structure, the nature of the bath gas, temperature, and E/N; (ii) ion mobility does not measure molecular surfaces directly, but collision cross section (CCS) values are derived from mobility values using a physical model; (iii) methods relying on calibration are empirical (and thus may provide method‐dependent results) only if the gas nature, temperature or E/N cannot match those of the primary method. Our analysis highlights the urgency of a community effort toward establishing primary standards and reference materials for ion mobility, and provides recommendations to do so. © 2019 The Authors. Mass Spectrometry Reviews Published by Wiley Periodicals, Inc.

18 March 2014 in Nature Communications
Verified
Journal Article
Open access
ZAZenita Adhireksan
Zenita Adhireksan
GDGabriela E. Davey
Gabriela E. Davey
Pablo CampomanesPablo Campomanes
Pablo Campomanes
MGMichael Groessl
Michael Groessl
CCCatherine M. Clavel
Catherine M. Clavel
CDCurt A. Davey
Curt A. Davey
Ruthenium compounds have become promising alternatives to platinum drugs by displaying specific activities against different cancers and favourable toxicity and clearance properties. Nonetheless, their molecular targeting and mechanism of action are poorly understood. Here we study two prototypical ruthenium-arene agents-the cytotoxic antiprimary tumour compound [(η(6)-p-cymene)Ru(ethylene-diamine)Cl]PF6 and the relatively non-cytotoxic antimetastasis compound [(η(6)-p-cymene)Ru(1,3,5-triaza-7-phosphaadamantane)Cl2]-and discover that the former targets the DNA of chromatin, while the latter preferentially forms adducts on the histone proteins. Using a novel 'atom-to-cell' approach, we establish the basis for the surprisingly site-selective adduct formation behaviour and distinct cellular impact of these two chemically similar anticancer agents, which suggests that the cytotoxic effects arise largely from DNA lesions, whereas the protein adducts may be linked to the other therapeutic activities. Our study shows promise for developing new ruthenium drugs, via ligand-based modulation of DNA versus protein binding and thus cytotoxic potential, to target distinguishing epigenetic features of cancer cells.

20 August 2015 in The Analyst
Verified
Journal Article
Closed access
PDF file
MGM. Groessl
M. Groessl
SGS. Graf
S. Graf
RKR. Knochenmuss
R. Knochenmuss
Separation and identification of isomeric species is a major challenge in lipidomics. Herein, we demonstrate that lipid isomers that differ only in position of the acyl chain, position of the double bond or double bond geometry can be distinguished using drift-tube ion mobility-mass spectrometry, even in complex biological samples.


23 February 2011 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
BWBin Wu
Bin Wu
MOMichelle S. Ong
Michelle S. Ong
MGMichael Groessl
Michael Groessl
ZAZenita Adhireksan
Zenita Adhireksan
CHChristian Hartinger
Christian Hartinger
CDCurt A. Davey
Curt A. Davey